Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.

BACKGROUND: The past three decades have seen rapid improvements in the diagnosis and treatment of most cancers and the most important contributor has been research. Progress in rare cancers has been slower, not least because of the challenges of undertaking research. SETTINGS: The International Rare Cancers Initiative (IRCI) is a partnership which aims to stimulate and facilitate the development of international clinical trials for patients with rare cancers. It is focused on interventional--usually randomized--clinical trials with the clear goal of improving outcomes for patients. The key challenges are organisational and methodological. A multi-disciplinary workshop to review the methods used in ICRI portfolio trials was held in Amsterdam in September 2013. Other as-yet unrealised methods were also discussed. RESULTS: The IRCI trials are each presented to exemplify possible approaches to designing credible trials in rare cancers. Researchers may consider these for use in future trials and understand the choices made for each design. INTERPRETATION: Trials can be designed using a wide array of possibilities. There is no 'one size fits all' solution. In order to make progress in the rare diseases, decisions to change practice will have to be based on less direct evidence from clinical trials than in more common diseases.

Emission Trading and Tradable Green Certificates Impacts on the Business Activity of Vattenfall Oy

Ihmisen toiminnan vaikutus ilmakehään johtaa todennäköisesti ilmastonmuutoksiin. Eräs näistä muutoksista on maapallon keskilämpötilan nousu, joka aiheutuu kasvihuonekaasujen lisääntyneestä pitoisuudesta ilmakehässä. Vaikutusten vähentämiseksi on hiilidioksidipäästöjä vähennettävä. Kioton pöytäkirja asettaa allekirjoittaneille maille päästövelvoitteet. Euroopan unionin tulee vähentää kasvihuonekaasupäästöjään 8%:lla. Eräs vähennysmekanismeista on päästökauppa. Päästökauppa on sekä keino suojella ympäristöä että ympäristöpoliittinen instrumentti kasvihuonekaasupäästövähennysten kustannusten keventämiseksi. Päästökauppa ei suoranaisesti vähennä kasvihuonekaasupäästöjä, vaan tasaa niitä maiden ja laitosten välillä. Uusiutuvan energian käytön edistäminen sekä kansainvälisesti että kansallisesti johtaa suoriin kasvihuonekaasupäästöjen vähenemiseen. Euroopan unionin jäsenvaltiot ovat asettaneet kansalliset viitearvot uusituvan sähkön kulutukselle. Saavuttaakseen nämä viitearvot maiden tulee tukea uusiutuvia energialähteitä eri menetelmin kuten vihreillä sertifikaateilla. Päästökauppa ja kaupattavat vihreät sertifikaatit tulevat vaikuttamaan energiantuottajien liiketoimintaan. Työssä on tutkittu päästökaupan ja vihreiden sertifikaattien vaikutuksia Vattenfall Kaukolämpö Oy:n, Vattenfall Sähköntuotanto Oy:n ja Vamy Oy:n liiketoimintaan.

Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.

The Prostate Cancer Programme of the European School of Oncology developed the concept of specialised interdisciplinary and multiprofessional prostate cancer care to be formalized in Prostate Cancer Units (PCU). After the publication in 2011 of the collaborative article "The Requirements of a Specialist Prostate Cancer Unit: A Discussion Paper from the European School of Oncology", in 2012 the PCU Initiative in Europe was launched. A multiprofessional Task Force of internationally recognized opinion leaders, among whom representatives of scientific societies, and patient advocates gathered to set standards for quality comprehensive prostate cancer care and designate care pathways in PCUs. The result was a consensus on 40 mandatory and recommended standards and items, covering several macro-areas, from general requirements to personnel to organization and case management. This position paper describes the relevant, feasible and applicable core criteria for defining PCUs in most European countries delivered by PCU Initiative in Europe Task Force.

Development process and initial validation of the ethical conflict in nursing questionnaire-critical care version

Background: Ethical conflicts are arising as a result of the growing complexity of clinical care, coupled with technological advances. Most studies that have developed instruments for measuring ethical conflict base their measures on the variables"frequency" and"degree of conflict". In our view, however, these variables are insufficient for explaining the root of ethical conflicts. Consequently, the present study formulates a conceptual model that also includes the variable"exposure to conflict", as well as considering six"types of ethical conflict". An instrument was then designed to measure the ethical conflicts experienced by nurses who work with critical care patients. The paper describes the development process and validation of this instrument, the Ethical Conflict in Nursing Questionnaire Critical Care Version (ECNQ-CCV). Methods: The sample comprised 205 nursing professionals from the critical care units of two hospitals in Barcelona (Spain). The ECNQ-CCV presents 19 nursing scenarios with the potential to produce ethical conflict in the critical care setting. Exposure to ethical conflict was assessed by means of the Index of Exposure to Ethical Conflict (IEEC), a specific index developed to provide a reference value for each respondent by combining the intensity and frequency of occurrence of each scenario featured in the ECNQ-CCV. Following content validity, construct validity was assessed by means of Exploratory Factor Analysis (EFA), while Cronbach"s alpha was used to evaluate the instrument"s reliability. All analyses were performed using the statistical software PASW v19. Results: Cronbach"s alpha for the ECNQ-CCV as a whole was 0.882, which is higher than the values reported for certain other related instruments. The EFA suggested a unidimensional structure, with one component accounting for 33.41% of the explained variance. Conclusions: The ECNQ-CCV is shown to a valid and reliable instrument for use in critical care units. Its structure is such that the four variables on which our model of ethical conflict is based may be studied separately or in combination. The critical care nurses in this sample present moderate levels of exposure to ethical conflict. This study represents the first evaluation of the ECNQ-CCV.

Development process and initial validation of the ethical conflict in nursing questionnaire-critical care version

Background: Ethical conflicts are arising as a result of the growing complexity of clinical care, coupled with technological advances. Most studies that have developed instruments for measuring ethical conflict base their measures on the variables"frequency" and"degree of conflict". In our view, however, these variables are insufficient for explaining the root of ethical conflicts. Consequently, the present study formulates a conceptual model that also includes the variable"exposure to conflict", as well as considering six"types of ethical conflict". An instrument was then designed to measure the ethical conflicts experienced by nurses who work with critical care patients. The paper describes the development process and validation of this instrument, the Ethical Conflict in Nursing Questionnaire Critical Care Version (ECNQ-CCV). Methods: The sample comprised 205 nursing professionals from the critical care units of two hospitals in Barcelona (Spain). The ECNQ-CCV presents 19 nursing scenarios with the potential to produce ethical conflict in the critical care setting. Exposure to ethical conflict was assessed by means of the Index of Exposure to Ethical Conflict (IEEC), a specific index developed to provide a reference value for each respondent by combining the intensity and frequency of occurrence of each scenario featured in the ECNQ-CCV. Following content validity, construct validity was assessed by means of Exploratory Factor Analysis (EFA), while Cronbach"s alpha was used to evaluate the instrument"s reliability. All analyses were performed using the statistical software PASW v19. Results: Cronbach"s alpha for the ECNQ-CCV as a whole was 0.882, which is higher than the values reported for certain other related instruments. The EFA suggested a unidimensional structure, with one component accounting for 33.41% of the explained variance. Conclusions: The ECNQ-CCV is shown to a valid and reliable instrument for use in critical care units. Its structure is such that the four variables on which our model of ethical conflict is based may be studied separately or in combination. The critical care nurses in this sample present moderate levels of exposure to ethical conflict. This study represents the first evaluation of the ECNQ-CCV.

Pairs Trading -strategia Suomen osakemarkkinoilla

Tutkielman tavoitteena on selvittää soveltuvatko suomalaiset osakkeet parikaupankäyntiin ja voidaanko niillä luoda tuottavia kaupankäyntistrategioita. Tutkielmassa tarkastellaan pystytäänkö suomalaisista osakkeista muodostamaan parikaupankäynnin kannalta toimivia osakepareja. Aineisto koostuu kaikkiaan 53 tutkitusta yrityksestä, joiden joukosta valitaan paras osakepari kultakin viideltä toimialalta. Tutkimusperiodi käsittää vuodet 2004–2007, eli se sisältää noin 1000 kaupankäyntipäivää per osa-ke. Viittä valittua osakeparia tutkitaan tarkemmin tilastollisilla ja teknisillä analyysimenetelmillä. Empiiristen tulosten perusteella suomalaiset osakkeet soveltuvat hyvin parikaupankäyntiin. Jokaisella viidellä tutkitulla osakeparilla ilmeni selvää hintojen erkaantumista ja konvergoitumista, joten niillä olisi tutkimuspe-riodin aikana pystynyt käymään menestyksekästä parikauppaa.

Gestion et communication de l'information en surveillance biologique. Une approche éthique et interdisciplinaire [Biomonitoring information management and communication: an ethical and interdisciplinary perspective]

This study explores biomonitoring communication with workers exposed to risks. Using a qualitative approach, semi-directive interviews were performed. Results show that occupational physicians and workers share some perceptions, but also point out communication gaps. Consequently, informed consent is not guaranteed. This article proposes some recommendations for occupational physicians' practices.